Allison Transmission (ALSN) Q2 2026 Earnings Call Transcript

Allison Transmission reported Q2 2026 net sales of $1.566B (+92% y/y), with adjusted EBITDA of $404M (+$91M y/y) and adjusted diluted EPS of $2.73 (+8% y/y). The company raised FY26 guidance to $5.8B–$6.0B revenue and $1.465B–$1.575B adjusted EBITDA (≈26% margin at midpoint), alongside 84% higher adjusted free cash flow to $281M in Q2. Despite near-term margin pressure from steel/aluminum (aluminum +~25% q/q), management expects cost recovery via customer indexing over a 6–12 month lag, while defense demand remains strong and long-lead order visibility extends into 2027.

Analysis

The setup is less about this quarter’s beat and more about the earnings-quality inflection that should show up over the next 2-4 quarters. The core business still has a margin catch-up path because pass-through lags are long enough to let reported profitability understate true pricing power; that creates a window where cash flow can re-rate before headline EPS fully catches up. With integration savings back-end loaded, 2026 looks like a transition year, but that also means the market may be underpricing the 2027 earnings step-up if pricing discipline holds.

Second-order, the defense backlog matters more as a durability signal than as near-term revenue. It should help reset investor expectations around end-market cyclicality and could pressure smaller drivetrain suppliers or niche defense contractors that lack comparable program visibility. The bigger near-term swing factor is vocational truck demand: any EPA-driven prebuy would lift ALSN’s legacy mix faster than the market expects, while Q3 seasonality in off-highway is a natural air pocket that could create a better entry point.

The contrarian view is that the stock may already be discounting too much of the good news from the acquisition and defense announcements, while missing that the real upside is in price/cost normalization and FCF conversion. If management proves the 2027 pricing narrative and legacy margins stop leaking despite stable builds, the multiple can expand before synergy dollars are fully realized. Falsifier: another quarter of compressed legacy margins without a sequential recovery in vocational volumes, or any evidence the commodity lag extends materially beyond the stated recovery window.

Key Decisions for Investors

• Buy ALSN on any post-earnings pullback over the next 1-2 sessions; 3-6 month thesis is margin reversion and 2027 EPS revision, not 2026 reported growth. Falsify if legacy margins stay compressed through Q3/Q4 despite stable builds.
• If implied volatility is still elevated, buy an ALSN 3-6 month 5-10% OTM call spread to express upside from EPA '27 prebuy and pricing recovery with defined risk. Exit if OEM commentary turns cautious on second-half build rates.
• Set a watch alert on ALSN's Q3 legacy gross margin and pricing commentary; add only if management confirms price/cost turns positive before year-end. Missing this inflection would argue the commodity lag is longer than expected.
• Treat BAESY and GD as confirmation trades, not primary longs: if those primes continue to convert defense awards into funded backlog, it supports ALSN's long-dated defense visibility. If order flow slows, trim ALSN upside assumptions rather than the core thesis.